The isolation and cloning of a full-length cDNA insert complementary to mRNA encoding human aromatase system cytochrome P-450 is reported. The insert contains an open reading frame encoding a protein of 503 amino acids. This gene is clearly a member of the cytochrome P450 gene superfamily, because the sequence contains regions of marked homology to those of other members, notably a putative membrane-spanning region, I helix, Ozols, and hemebinding regions. The cDNA was inserted into a modified pCMV vector and expressed in COS-1 monkey kidney tumor cells. The expressed protein was similar in size to human placental aromatase system cytochrome P-450, as detected by immunoblot analysis, and catalyzed the aromatization of androstenedione, testosterone, and 16a-hydroxyandrostenedione. This activity was inhibited by the known aromatase inhibitors, 4-hydroxyandrostenedione and econazole. Thus the several steps involved in the aromatization reaction appear to be catalyzed by a single polypeptide chain, which can metabolize the three major physiological substrates.
The conversion of androgens to estrogens is catalyzed by an enzyme complex named aromatase. This complex is comprised of a specific form of cytochrome P-450, aromatasesystem cytochrome P-450 (P450Aom), and the flavoprotein NADPH-cytochrome P-450 reductase (1) (2) (3) . The components of this enzyme complex are located in the endoplasmic reticulum of the tissue sites of expression, including the syncytiotrophoblast of the placenta, granulosa cells of the ovary (4) , testicular Sertoli cells (5) , adipose tissue (6), hypothalamus, hippocampus, and amygdala of the brain (7) (8) (9) , and the preimplantation blastocyst (10) . In these tissue sites the enzyme is subject to complex multifactorial regulation by a diverse group of factors including gonadotropins and cyclic AMP, glucocorticoids, phorbol esters, and a number of growth factors such as transforming growth factor ,3, epidermal growth factor, fibroblast growth factor, as well as tumor necrosis factor (11) . Aromatization of the A ring of A4-3-one steroids to form the phenolic A ring characteristic of estrogens has been shown to require 3 mol of oxygen and 3 mol of NADPH for every mol of steroid biosynthesized (12) . Utilization of the first two oxygen molecules is believed to result in sequential hydroxylation of the C19 angular methyl group with its subsequent loss. The site of attack by the third oxygen molecule has not been determined but has been suggested to result in the formation of a 2,B-hydroxyl group with concomitant nonenzymatic collapse of the resultant intermediate, giving rise to the phenolic A ring (13) .
In addition to defining the mechanisms underlying the multifactorial and tissue-specific regulation of this enzyme, a number of important questions remain unanswered. (i) Because different products are formed in different tissue sitesnamely, estriol in the placenta, estradiol in the ovary, and estrone in the adipose tissue-it has been suggested that there exist two or more forms of the aromatase enzyme with different substrate specificities (14) . Alternatively, these various products could result from the nature of the substrates that are presented to the enzyme in each of these tissues-namely, 16a-hydroxylated C19 steroids in the placenta, testosterone in the ovary, and androstenedione in adipose tissue. (ii) Because the production of 19-hydroxy-, 19- (16) . A 20-base pair (bp) oligonucleotide was used to prime first-strand cDNA synthesis under the modified condition described by Gubler and Hoffman (17) . Second-strand cDNA synthesis was accomplished using RNase H and Escherichia coli DNA polymerase I (17) . The termini of the doublestranded cDNA molecules were blunted with T4 DNA polyAbbreviation: P-450Am, aromatase system cytochrome P-450 [the product of the CYP19 or P450XIX gene (27) ]. *To whom reprint requests should be addressed. tThe sequence reported in this paper is being deposited in the EMBL/GenBank data base (accession no. J04127).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. merase I (17) . The termini of the double-stranded cDNA molecules were blunted with T4 DNA polymerase (18) and then methylated with EcoRI methylase. Synthetic EcoRI linkers were attached, and the cDNA (100 ng) was then ligated into phosphatased AgtlO arms (Promega Biotec, Madison, WI) and packaged in vitro. After plating of the library (7 x 104 plaque-forming units) on the restrictive host, C600 Hfl-, the library was screened using a cDNA fiagment priming toward the 5' terminus. Positive clones were purified to homogeneity, and the inserts were characterized as described below.
Double-Stranded Sequencing. Amplified plugs from the sixth screening of a human placental AgtlO cDNA library (screened using the 2.5-kb cDNA insert previously isolated from a human placental Agtll library; ref. 19) were cut with HindIII and Bgl II. The resulting 4.0-kilobase (kb) insert, which was flanked by some vector sequence, was subcloned into pUC19. Double-stranded sequencing was performed using oligonucleotides priming to the 5' end of the 2.5-kb insert and subsequently to a site -160 bp upstream from this end.
Expression in COS-1 Cells. P-45OArom cDNA was cleaved from pUC19 by first digesting with Stu I, which cleaves in the 3' untranslated region of the cDNA, 301 bp from the TAG stop codon, and then partially digested with EcoRI. The resultant 1.9-kb fragment was isolated from a 1.0% lowmelting-point agarose gel and ligated into the EcoRI/Sma I sites of the eukaryotic expression vector pCMV2 to produce Northern (RNA) and Western (Immunologic) Analyses of RNA and Proteins in Transfected COS-1 Cells. These analyses were conducted as described (20 Hydropathy Analysis. Hydropathy measurements were performed by the method of Kyte and Doolittle using a window of six residues (22) . The output ofthese analyses was transferred to the LOTUS 1-2-3 program, the values were then aligned (where necessary, gaps were placed between data points), and plots were made using the SIGMA-PLOT program.
RESULTS AND DISCUSSION
Isolation and Characterization of a Full-Length cDNA Encoding Human P450AOm. The present report documents the isolation and characterization of a full-length cDNA insert complementary to human P-45OArom. The sequence of the full-length cDNA insert encoding P-450,om is shown in Fig.   1 ; this insert is 2736 bp in length. We previously reported the sequencing of an -2.5-kb insert, isolated from a human placental Agtll library, in which the sequence commenced at the site indicated by the second arrow (19, 23) . A similar sequence was recently reported by Chen et al. (24) , which also started at this site. To obtain sequence upstream from this site we prepared a primer-extended library using poly(A)+ RNA from human placenta as indicated in Materials and Methods. Twelve clones were isolated from the primer-extended library. Of these, a single clone was found to extend beyond the internal EcoRl restriction site indicated in Fig. 1 . This clone was sequenced. A second clone was isolated from a AgtlO library prepared from human placental RNA (donated by P. Seeburg, Genentech) and screened using the 2.5-kb cDNA insert. This latter insert was 4.0 kb in length and was ligated into pUC19. The 5' end was sequenced by the double-stranded method and was found to have a sequence identical to the clone from the primer-extended library.
Primary and Secondary Structure of Human P-450A,,O. The sequence of the full-length cDNA is shown in Fig. 1 . The amino acid sequence of human P-45OArom was derived from the open reading frame and compared with that ofother forms of cytochrome P-450. There is an open reading frame starting with an ATG that is 39 bp from the 5' end of the cDNA and that continues for another 1509 bases-i.e., 503 amino acids-to a TAG stop codon. We consider this ATG to be the start of translation because the following 10 amino acids, beginning with valine and ending with tyrosine, are identical to the amino-terminal sequence of the purified P-450Arom reported by Chen et al. (2) . This latter sequence lacks the initiating methionine. Furthermore, there are no ATG sequences upstream of this site in the cDNA, and the corresponding ATG in the sequence of a full-length chicken cytochrome P-45OArom cDNA, which has recently been characterized and expressed by McPhaul et al. (18) , is the start of the open reading frame of that insert. The present derived sequence diverges markedly from that of Chen et al. (2) after Tyr-11 but retains pronounced homology with that of chicken P-45OArom (18) .
The derived coding region of P-450Arom clearly indicates that this polypeptide belongs to a member of the cytochrome P450 superfamily of genes. Generally, no greater than 30% sequence homology was found between P-45OArom and other forms of cytochrome P450, indicating that cytochrome P4SOAom, in common with other steroidogenic P-450 species, belongs to a separate gene family within the overall superfamily, designated cytochrome P-45OXIX (25) . The most highly conserved region is the carboxy-terminal 200 residues that contain Ozols (residues 349-371), aromatic (residues 407-418), and heme-binding (residues 430-443) regions, and the I helix (residues 290-324). Near the carboxy-terminal end is the region believed to be the heme-binding region. Within this sequence is a cysteine, indicated by underlining, which is common to all cytochrome P450s, and is believed to be the fifth coordinating ligand of the heme iron (Fig. 1) . The amino acid sequence of this heme-binding region shows marked homology with that of the other steroidogenic forms of P-450 so far determined (19) .
The Ozols region, the second most conserved region in all P450 species, has been suggested to be involved in substrate binding (26) . In human P-450Arom, both Glu-362 and Arg-365 are conserved. Also Pro-368 and Val-369 appear to be conserved among the steroidogenic P-450s. In addition, near the amino-terminal end there is a highly hydrophobic region (residues 23-39), present in all microsomal P-450 species and believed to be the membranespanning domain.
From the hydropathy plots of human P-450Arom, human P-45017m, human P-450c21, and P-450c. shown in Fig. 2 , the region corresponding to the I helix (indicated by I) shows a characteristic hydrophobic double peak. In P450cam, in which the three-dimensional structure has been determined by x-ray crystallography (27) , the I helix is a hydrophobic backbone through the center of the molecule, which along with the L helix and heme-binding region, interacts with the heme molecule (27) . Also in these plots one can identify the putative membrane-spanning region (indicated by M) at the amino-terminal end. When comparing the sequence of this region in P-450ArOm with those of the other P450s, an additional 22 residues are found between the initiating methionine and the membrane-spanning domain of P-45OArom (Fig. 1) ; these residues are also present in some hydrocarbonmetabolizing forms of cytochrome P-450, such as P-450C of rat (28) .
The sequence of the cDNA insert shown in Fig. 1 does not contain a poly(A)+ tail, but terminates in a guanine, which possibly is the start of another EcoRI restriction site. However, within the sequence of the 3' untranslated region and indicated by underlining, there is a polyadenylylation signal. Twenty-one bases downstream from that and indicated by the third arrow is the start of the poly(A)+ tail of another cDNA insert complementary to P-450Arom, which we isolated from the same Agtll library as the 2.5-kb insert (19, 23) . These clones then appear to differ by the alternative use of more than one polyadenylylation signal but are otherwise identical. The existence, therefore, of two mRNA species of different size would be anticipated, and this is indeed what we have found in human placenta, granulosa cells, and adipose stromal cells (19, 29, 30) .
Expression of Human P-450Om in COS-1 Cells. To determine whether this cDNA encodes a protein possessing aromatase activity, the insert was ligated into a modified pCMV vector and used to transfect COS-1 monkey kidney tumor cells. Three days after transfection, RNA was extracted and subjected to Northern analysis with the 2.5-kb insert as hybridization probe. As shown in Fig. 3 , a single hybridizing species of RNA of 2.1 kb was seen, consistent with the anticipated size of the expressed construct. To determine whether this RNA was translated into protein, whole cell protein extract was subjected to Western analysis, with use ofthe polyclonal anti-P-450 IgG (1) . As shown in Fig.  3 the overall aromatase reaction, resulting in the formation of a phenolic A ring from the A4-3-one structure ofthe substrate.
(ii) It is apparent from the results in Table 1 that the single polypeptide chain encoded by this cDNA can utilize three major substrates for aromatization-namely, androstenedione, testosterone, and 16a-hydroxyandrostenedione. It is unnecessary, therefore, to postulate the existence of several forms of aromatase in the ovary, adipose tissue, and placenta responsible for forming the different phenolic steroids in these tissues. We conclude that probably only one enzyme responsible for the aromatization of C19 steroids is present in humans.
The fact that two species of mRNA are present in tissues that express aromatase activity can be explained by the alternative use of different polyadenylylation signals. This conclusion is consistent with our preliminary studies to isolate and characterize the gene encoding human cytochrome P450Arom. From such investigations we have obtained no evidence for more than one gene encoding this enzyme. §
